Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2020 Jun 22;S1569-1993(20)30779-7. doi: 10.1016/j.jcf.2020.06.015. Online ahead of print
Document
Link
Keywords
Date
Monday, June 22, 2020
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [7]